The To***co Research Center is based at the University of California, San Francisco as a part of the Division of Clinical Pharmacology & Experimental Therapeutics in the Department of Medicine, in cooperation with Zuckerberg San Francisco General. More than 5 million people die each year due to to***co-related illnesses. We know that most smokers want to quit, but only 5% actually succeed each yea
r. And every day, more than 3,800 youths under the age of 18 smoke their first cigarette. (https://www.cdc.gov/to***co/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm)
Why does this happen? Because ni****ne is very addictive and takes away the choice of being able to quit or not. Ni****ne also leads to young adults, kids, who try smoking - even just one time - to become addicted. Our research focuses primarily on human pharmacology of ni****ne and other drugs with the goal of improving the health of potentially millions. The center has been studying the questions related to the safety of reduced ni****ne ci******es, low tar ci******es, safety of medications used to treat ni****ne addiction, smoking and heart disease, smokeless to***co, electronic ci******es, and the genetics of ni****ne addiction.
